Biosynth, a developer and supplier of critical raw materials and services for life sciences and diagnostics, has opened an expanded GMP bioconjugation facility at its existing Berlin site.

Körber’s Business Area Pharma now offers a standardized approach to connect systems and equipment to its market-leading PAS-X ...

The CDMO has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line. As a ...

Axplora has announced a transformative €35 million ($41.2 million) expansion at its Farmabios site in Gropello Cairoli, Italy ...

Pace Life Sciences LLC is remodeling and expanding its Salem, NH, site to establish a Center of Excellence for Aseptic ...

Circio Holding ASA, a biotechnology company developing circular RNA technology for next generation nucleic acid medicine, has ...

The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff.

Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will continue to serve as Chief Scientific ...

BioMarin Pharmaceutical Inc. has completed the previously announced agreement to acquire Inozyme Pharma Inc. for $4.00 per ...

Fresenius announced that its operating company, Fresenius Kabi, has introduced two new biosimilars – Conexxence ...

Merck KGaA, Darmstadt, Germany has closed the acquisition of SpringWorks Therapeutics Inc. for an enterprise value of $3.4 billion.